JP2021511374A5 - - Google Patents

Info

Publication number
JP2021511374A5
JP2021511374A5 JP2020560532A JP2020560532A JP2021511374A5 JP 2021511374 A5 JP2021511374 A5 JP 2021511374A5 JP 2020560532 A JP2020560532 A JP 2020560532A JP 2020560532 A JP2020560532 A JP 2020560532A JP 2021511374 A5 JP2021511374 A5 JP 2021511374A5
Authority
JP
Japan
Prior art keywords
group
hydrocarbon
heterocyclic
stereoisomer
solvate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020560532A
Other languages
English (en)
Japanese (ja)
Other versions
JP7352297B2 (ja
JP2021511374A (ja
Filing date
Publication date
Priority claimed from CN201810044308.4A external-priority patent/CN110041327B/zh
Priority claimed from CN201811517425.4A external-priority patent/CN111303147B/zh
Application filed filed Critical
Priority claimed from PCT/CN2019/071902 external-priority patent/WO2019141179A1/zh
Publication of JP2021511374A publication Critical patent/JP2021511374A/ja
Publication of JP2021511374A5 publication Critical patent/JP2021511374A5/ja
Application granted granted Critical
Publication of JP7352297B2 publication Critical patent/JP7352297B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020560532A 2018-01-17 2019-01-16 ピリドン誘導体と、その組成物、並びにそれらが抗ウイルス薬物としての応用 Active JP7352297B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN201810044308.4A CN110041327B (zh) 2018-01-17 2018-01-17 吡啶酮衍生物、其组合物及作为抗流感病毒药物的应用
CN201810044308.4 2018-01-17
CN201811517425.4A CN111303147B (zh) 2018-12-12 2018-12-12 吡啶酮衍生物、其组合物及作为抗流感病毒药物的应用
CN201811517425.4 2018-12-12
PCT/CN2019/071902 WO2019141179A1 (zh) 2018-01-17 2019-01-16 吡啶酮衍生物、其组合物及作为抗流感病毒药物的应用

Publications (3)

Publication Number Publication Date
JP2021511374A JP2021511374A (ja) 2021-05-06
JP2021511374A5 true JP2021511374A5 (cg-RX-API-DMAC7.html) 2022-03-15
JP7352297B2 JP7352297B2 (ja) 2023-09-28

Family

ID=67301986

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020560532A Active JP7352297B2 (ja) 2018-01-17 2019-01-16 ピリドン誘導体と、その組成物、並びにそれらが抗ウイルス薬物としての応用

Country Status (13)

Country Link
US (1) US11247993B2 (cg-RX-API-DMAC7.html)
EP (1) EP3753936B1 (cg-RX-API-DMAC7.html)
JP (1) JP7352297B2 (cg-RX-API-DMAC7.html)
KR (1) KR102477187B1 (cg-RX-API-DMAC7.html)
CN (4) CN111848615B (cg-RX-API-DMAC7.html)
AU (1) AU2019210414B2 (cg-RX-API-DMAC7.html)
CA (1) CA3088926A1 (cg-RX-API-DMAC7.html)
ES (1) ES3074017T3 (cg-RX-API-DMAC7.html)
PH (1) PH12020551264A1 (cg-RX-API-DMAC7.html)
PT (1) PT3753936T (cg-RX-API-DMAC7.html)
SG (1) SG11202011447UA (cg-RX-API-DMAC7.html)
WO (1) WO2019141179A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202007143B (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2881776T3 (es) 2016-03-08 2021-11-30 Novartis Ag Compuestos tricíclicos útiles para tratar las infecciones por ortomixovirus
JOP20170169A1 (ar) 2016-08-29 2019-01-30 Novartis Ag مركبات بيريدازين ثلاثية الحلقة مندمجة تفيد في علاج العدوى بفيروس أورثوميكسو
US11286262B2 (en) 2017-10-06 2022-03-29 Shionogi & Co., Ltd. Stereoselective process for preparing substituted polycyclic pyridone derivatives
HUE069183T2 (hu) * 2018-02-28 2025-02-28 Novartis Ag 10-(di(fenil)metil)-4-hidroxi-8,9,9a,10-tetrahidro-7H--pirrolo[1',2':4,5]pirazino[1,2-b]piridazin-3,5-dion származékok és kapcsolódó vegyületek mint orthomyxovírus repikáció gátlók influenza kezelésére
WO2020205835A1 (en) * 2019-04-01 2020-10-08 Nikang Therapeutics, Inc. Fused polycyclic pyridone compounds as influenza virus replication inhibitors
CN111909174B (zh) 2019-05-08 2022-01-21 江西彩石医药科技有限公司 吡啶酮衍生物的晶型及制备方法和应用
CN112574170A (zh) * 2019-09-29 2021-03-30 江西东邦药业有限公司 一种二苯并七元环衍生物及其制备方法和应用
CN115135646B (zh) * 2019-12-23 2024-05-17 石家庄迪斯凯威医药科技有限公司 取代的多环化合物及其药物组合物和用途
CN113045589B (zh) * 2019-12-27 2024-08-23 广东东阳光药业股份有限公司 流感病毒复制抑制剂及其用途
CN112898346B (zh) * 2020-01-23 2023-11-10 南京知和医药科技有限公司 水溶性多环化合物及其药物组合物和用途
CN113116899B (zh) * 2020-03-06 2022-12-20 广东众生睿创生物科技有限公司 一种用于治疗流感的药物组合物及含有该药物组合物的制剂
CN111943879A (zh) * 2020-08-03 2020-11-17 南通大学 一种(3s,4r)3-氨基-4(甲氧基甲基)吡咯烷-1-甲酸叔丁酯及其合成方法
CN120289488A (zh) * 2020-08-11 2025-07-11 石家庄迪斯凯威医药科技有限公司 多环化合物及其药物组合物和用途
CN115385932A (zh) * 2021-05-22 2022-11-25 江西彩石医药科技有限公司 吡啶酮衍生物的中间体及其制备方法
CN117003766B (zh) * 2022-10-08 2024-02-02 石家庄迪斯凯威医药科技有限公司 一种抗流感病毒衍生物及其用途
WO2024098856A1 (zh) * 2022-11-09 2024-05-16 石家庄迪斯凯威医药科技有限公司 一种抗流感病毒衍生物及其用途
CN116789556A (zh) * 2023-05-26 2023-09-22 康化(上海)新药研发有限公司 一种含环丙氧基乙胺的制备方法
WO2026145578A1 (zh) * 2024-12-30 2026-07-09 江西科睿药业有限公司 固体分散体、药物组合物及其制备方法与应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5737691B2 (ja) 2009-06-15 2015-06-17 塩野義製薬株式会社 置換された多環性カルバモイルピリドン誘導体
LT2620436T (lt) 2010-09-24 2018-08-10 Shionogi & Co., Ltd. Pakeistojo policiklinio karbamoilpiridono darinio provaistas
CN105764904B (zh) * 2013-09-12 2020-02-11 詹森生物制药有限公司 氮杂-吡啶酮化合物及其用途
CN107709321A (zh) * 2015-04-28 2018-02-16 盐野义制药株式会社 经取代的多环性吡啶酮衍生物及其前药
HK1254961A1 (en) * 2015-12-15 2019-08-02 Shionogi & Co., Ltd. Medicine for treating influenza characterized by comprising combination of cap-dependent endonuclease inhibitor with anti-influenza drug
JP6806413B2 (ja) 2016-02-03 2021-01-06 塩野義製薬株式会社 多環性ピリドン誘導体およびそのプロドラッグ
US10759814B2 (en) * 2016-08-10 2020-09-01 Shionogi & Co., Ltd. Pharmaceutical compositions containing substituted polycyclic pyridone derivatives and prodrug thereof
JOP20170169A1 (ar) 2016-08-29 2019-01-30 Novartis Ag مركبات بيريدازين ثلاثية الحلقة مندمجة تفيد في علاج العدوى بفيروس أورثوميكسو

Similar Documents

Publication Publication Date Title
RU2403258C2 (ru) Тиазолилдигидроиндазолы
RU2397168C2 (ru) Производные тиофена в качестве ингибиторов снк 1
ES2155817T3 (es) Inhibicion de la actividad de la quinasa p38 utilizando ureas heterociclicas sustituidas con arilo y heteroarilo.
RU2428428C2 (ru) Серусодержащие соединения, действующие как ингибиторы сериновой протеазы ns3 вируса гепатита с
CA2422367A1 (en) Pyrazole compounds useful as protein kinase inhibitors
JP2006515858A5 (cg-RX-API-DMAC7.html)
TW313565B (cg-RX-API-DMAC7.html)
CA2405521A1 (en) Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising n-cyclic p2 moieties
JP2022506887A5 (cg-RX-API-DMAC7.html)
EA201991684A1 (ru) Аналоги атазанавира (atv) для лечения вич-инфекций
RU2014140739A (ru) Соединения на основе имидазо[1, 2-b]пиридазина, композиции таких соединений и способы их применения
HRP20210775T1 (hr) Predlijekovi fenolnih agonista trpv1
HRP20241197T1 (hr) Makrociklični spojevi i primjene istih
JP2021501756A5 (cg-RX-API-DMAC7.html)
EA200501326A1 (ru) Пиримидины и триазины, ингибирующие репликацию вич
TW200745029A (en) Sulfonamide derivatives exhibiting PGD2 receptor antagonism
AR099367A1 (es) Inhibidores de la tirosina quinasa de bruton
EA201650029A1 (ru) Пиразолопиридины и пиразолопиримидины
AR064319A1 (es) Compuestos y composiciones farmaceuticas derivadas de sulfonamida ciclicos, proceso de preparacion y usos en el tratamiento de trastornos vasomotrices, sexuales, gastrointestinales y otros
HRP20180081T1 (hr) Fuzionirani triciklični heterociklični spojevi kao inhibitori hiv integraze
HRP20212020T1 (hr) Derivati parazola zgušenog prstena i njihova priprema i njihova primjena u liječenju raka, upale i imunoloških bolesti
CA2565852C (en) 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands
JP2021511374A (ja) ピリドン誘導体と、その組成物、並びにそれらが抗ウイルス薬物としての応用
HRP20220479T1 (hr) Spojevi
JP2015526453A5 (cg-RX-API-DMAC7.html)